alefacept

Safety and Tolerability of Repeat Courses of IM Alefacept

Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma

Alefacept in Patients With Severe Scalp Alopecia Areata

Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis

A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris

Alefacept in Patients With Relapsed/Refractory Aplastic Anemia

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

Inducing Remission in Type 1 Diabetes With Alefacept

A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients

A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients

Alefacept for Chronic Graft Versus Host Disease

A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis

Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis

Community Based Trial for AMEVIVE®

A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis

Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers

Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy